Track the Poolbeg Pharma plc share price and the full management transaction log of the company, a publicly traded company based in United Kingdom. Shares are quoted on the UK market, under the oversight of RNS (LSE). Market capitalisation: €68.7m. The latest transaction was reported on 25 June 2025 (Purchase). Among the most active insiders: Cathal Friel. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Poolbeg Pharma plc is a biopharmaceutical company focused on developing treatments for infectious diseases. It utilizes a drug discovery platform to identify and develop therapeutic candidates.